AVEO Pharmaceuticals, Inc.
Anti-GDF15 antibodies
Last updated:
Abstract:
Monoclonal antibodies that bind and inhibit the activity of human GDF15 are disclosed. The antibodies can be used to treat body weight loss, including cachexia, associated with the over-expression of human GDF15.
Status:
Grant
Type:
Utility
Filling date:
20 Jul 2017
Issue date:
24 Mar 2020